IE36687L - Morphinan derivatives - Google Patents

Morphinan derivatives

Info

Publication number
IE36687L
IE36687L IE721213A IE121372A IE36687L IE 36687 L IE36687 L IE 36687L IE 721213 A IE721213 A IE 721213A IE 121372 A IE121372 A IE 121372A IE 36687 L IE36687 L IE 36687L
Authority
IE
Ireland
Prior art keywords
hydroxy
methoxy
morphinan
methoxymorphinan
alkyl
Prior art date
Application number
IE721213A
Other versions
IE36687B1 (en
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of IE36687L publication Critical patent/IE36687L/en
Publication of IE36687B1 publication Critical patent/IE36687B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/36—Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/28—Morphinans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

1412129 Morphinane derivatives BRISTOL MYERS CO 7 Sept 1972 [8 Sept 1971 13 Jan 1972] 41619/72 Heading C2C [Also in Division A5] The invention comprises compounds of the formula (XXXX) wherein R<SP>1</SP> is -CH 2 -C # CH, or C 3-7 alkenyl in which R<SP>4</SP> is H or CH 3 , R<SP>2</SP> is H, C 1-6 alkyl, C 2-6 acyl CH 3 .C(CH 3 ) 2 .COCH 3 OCH 2 - or and R is H, C 2-6 acyl, trichloroacetyl or cinnamoyl. Compounds XXXX where R<SP>2</SP> and R are H can be obtained by treating a compound XXXX (where R is H, R 3 is C 1-7 alkyl, and R<SP>1</SP> is H, with an alkylating or acylating agent W-(Z)-X, where W is -C # CH, -CH = CH 2 , -CH = C(CH 3 ) 2 and C 2-6 alkenyl, Z is -CO- or -CH 2 -, X is Cl, Br or I, in an inert organic solvent in the presence of a tert. amine to form a compound XXXX (R is H, R 2 is alkyl, R<SP>1</SP> is -(Z)-W), treating the product with LiAlH 4 when Z is -CO- and cleaving the ether R<SP>2</SP>O- using HBr, BBr 3 or pyridine.HCl. Compounds in which R<SP>1</SP> is -CH 2 C # CH, -CH 2 -CH = CH 2 , -CH 2 -CH = C(CH 3 ) 2 , -CH 2 -CH = CH-Cl or C 3-7 alkenyl, are obtained by treating or compound XXXX (where R and R<SP>1</SP> are H, R 2 is alkyl) with R<SP>1</SP>-X, where X is Cl, Br or I, in an inert organic solvent in the presence of a tert. amine, and cleaving the ether as above. A further preparation comprises reacting a compound of Formula XXXXIIb where R<SP>2</SP> is C 1-7 alkyl with W-(Z)-X (where W is R 4 -substituted-cyclopropyl or cyclobutyl or 1-methylcyclopropyl), epoxidizing the product and reacting the epoxide with LiAlH 4 to form a compound XXXX (where R is H, R<SP>2</SP> is alkyl and R<SP>1</SP> is -CH 2 W), and optionally acylating the 14- hydroxy group and/or cleaving the ether group R<SP>2</SP>O-. Preparation of the following series of intermediates and products is also described: 3,4- dihydro - 7 - methoxy - 2,2 - tetramethylene- 1(2H) - naphthalenone; 1 - hydroxy - 7 - methoxy - 1,2,3,4 - tetrahydro - 2,2 - tetramethylene- 1 -naphthaleneacetonitrile; 1-(2-amino)-7-methoxy - 1,2,3,4 - tetrahydro - 2,2 - tetramethylene- 1 - naphthol; 4a - (2 - aminoethyl) - 1,2,3,4,4a,9- hexahydro - 6 - methoxyphenanthrene; 4a- [2 - (ethoxycarbonylamino)ethyl] - 1,2,3,4,4a,9- hexahydro - 6 - methoxyphenanthrene; 10,10a- α - epoxy - 4a - [2 - (ethoxycarbonylamino)- ethyl] 1,2,3;4,4a9,10,10a - octahydro - 6 - methoxyphenanthrene; N - ethoxy - carbonyl- 14 - hydroxy - 3 - methoxyisomorphinan; 14- hydroxy - 3 - methoxy - N - methylisomorphinan; N-ethoxycarbonyl-3-methoxy-#<SP>8</SP>-morphinan; 8,14# - epoxy - N - ethoxycarbonyl- 3 - methoxymorphinan (mixed isomers); N- ethoxycarbonyl - 14 - hydroxy - 3 - methoxymorphinan; 14-hydroxy-3-methoxy-N-methylmorphinan; 3,14 - dihydroxy - N - methyl morphinan; 3 - methoxy - #<SP>8,14</SP> - morphinan; N - cyclopropylcarbonyl - 3 - methoxy - #<SP>8,14</SP>- morphinan; N - cyclopropylcarbonyl - 8,14- epoxy - 3 - methoxymorphinan; N - cyclopropylmethyl - 14 - hydroxy - 3 - methoxymorphinan; 3,14 - dihydroxy - N - cyclopropylmethylmorphinan; 3 - methoxy - N - trifluoroacetyl- #<SP>8,14</SP> - morphinan; 8,14 - epoxy - 3 - methoxy- N - trifluoroacetylmorphinan; 8,14 - epoxy - 3 - methoxy morphinan; 14 - hydroxy- 3-methoxymorphinan; 3,14-dihydroxy-morphinan; N - cyclobutylcarbonyl - 14, - hydroxy- 3 - methoxymorphinan; N - cyclobutylmethyl- 14 - hydroxy - 3 - methoxy - morphinan; N- cyclobutylmethyl - 3,14 - dihydroxymorphinan; N - allyl - 14 - hydroxy - 3 - methoxymorphinan; N - allyl - 3,14 - dihydroxymorphinan; N- dimethyl - allyl - 14 - hydroxy - 3 - methoxymorphinan; N - dimethylallyl - 3,14 - dihydroxymorphinan; N - 2<SP>1</SP>- methylallyl - 14 - hydroxy - 3 - methoxy - morphinan; N - 2 - methylallyl-3,14-dihydroxy morphinan; N-cyclopropylmethyl - 3 - acetoxy - 4 - hydroxymorphinan; N - cyclopropylmethyl - 3 - isonicotinolyoxy- 14 - hydroxymorphinan; N - cyclobutylmethyl - 14 - hydroxy - 3 - methoxymethyloxymorphinan; N - cyclobutylmethyl - 3,14 - diacetoxy - morphinan; N - cyclobutylmethyl- 14 - acetoxy 3 - hydroxymorphinan; d and lisomers of 3,14-dihydroxy-N-cyclopropylmethylmorphinan. [GB1412129A]
IE1213/72A 1971-09-08 1972-09-06 N-substituted-14-hydroxy-3-substituted morphinan derivatives IE36687B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17883771A 1971-09-08 1971-09-08
US00217633A US3819635A (en) 1971-09-08 1972-01-13 14-hydroxymorphinan derivatives

Publications (2)

Publication Number Publication Date
IE36687L true IE36687L (en) 1973-03-08
IE36687B1 IE36687B1 (en) 1977-02-02

Family

ID=26874723

Family Applications (2)

Application Number Title Priority Date Filing Date
IE1213/72A IE36687B1 (en) 1971-09-08 1972-09-06 N-substituted-14-hydroxy-3-substituted morphinan derivatives
IE103/76A IE36688B1 (en) 1971-09-08 1972-09-06 3-substituted-morphinan derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
IE103/76A IE36688B1 (en) 1971-09-08 1972-09-06 3-substituted-morphinan derivatives

Country Status (19)

Country Link
US (1) US3819635A (en)
JP (1) JPS5310596B2 (en)
AU (1) AU470102B2 (en)
BE (1) BE788478A (en)
CA (1) CA999578A (en)
CH (1) CH590845A5 (en)
CY (1) CY980A (en)
DD (1) DD100255A5 (en)
DE (3) DE2265256C2 (en)
DK (1) DK141624B (en)
FR (1) FR2154481B1 (en)
GB (2) GB1412129A (en)
HK (1) HK2679A (en)
IE (2) IE36687B1 (en)
KE (1) KE2911A (en)
MY (1) MY7900027A (en)
NL (1) NL162072C (en)
SE (2) SE398877B (en)
YU (1) YU45099B (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910920A (en) * 1973-11-07 1975-10-07 Bristol Myers Co 3,14,17-Substituted-6,7-tetramethylenemorphinans
US3980641A (en) * 1975-07-31 1976-09-14 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinans
US4017497A (en) * 1975-11-18 1977-04-12 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinan derivatives
US4058531A (en) * 1976-03-23 1977-11-15 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinan derivatives
JPS52136176A (en) * 1976-03-23 1977-11-14 Bristol Myers Co Method of improving 144hydroxymorphinan derivatives
US4139534A (en) * 1977-02-17 1979-02-13 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinan derivatives
US4052389A (en) * 1976-03-23 1977-10-04 Bristol-Myers Company Derivatives of 9,10-dihydroxy-1-(p-alkoxybenzyl)-perhydroisoquinoline oxazine-3-one
GB1587831A (en) * 1977-03-23 1981-04-08 Reckitt & Colmann Prod Ltd Morphine derivatives
GB1593191A (en) * 1977-03-23 1981-07-15 Reckitt & Colmann Prod Ltd Derivatives of morphine
US4115389A (en) * 1977-05-02 1978-09-19 Bristol-Myers Company Process of N-demethylating (-)-1-(p-methoxybenzyl)-2-methyl-1,2,3,4,5,6,7,8-octahydroisoquinoline
US4338320A (en) * 1978-11-15 1982-07-06 The Board Of Regents Of The University Of Nebraska Esters of 6'-hydroxycinchonine, and a method of treating arrythmia with them
US4228285A (en) * 1979-02-28 1980-10-14 Bristol-Myers Company 14-Hydroxy-6-oxamorphinans and 14-hydroxy-6-oxaisomorphinans
US4272540A (en) * 1979-04-24 1981-06-09 Sisa, Incorporated 14-Methoxymorphinan-6-one compounds and therapeutic methods of treating pain and drug dependence with them
US4322427A (en) * 1981-04-16 1982-03-30 Bristol-Myers Company Analgetic compositions and methods of use
EP0661283B1 (en) * 1993-07-19 1998-10-21 Toray Industries, Inc. Brain cell protective
CA2143864C (en) * 1993-07-23 2006-01-24 Hiroshi Nagase Morphinan derivatives and pharmaceutical use thereof
CZ281174B6 (en) * 1993-08-13 1996-07-17 Galena, A.S. Process for preparing 3,14beta-dihydroxy-17-normorphinan
ATE265846T1 (en) 1998-02-25 2004-05-15 Abbott Lab SUSTAINED RELEASE FORMULATIONS CONTAINING BUTORPHANOL
US20040167164A1 (en) * 1998-05-05 2004-08-26 Jose Pozuelo Compositions and methods for treating particular chemical addictions and mental illnesses
US7501433B2 (en) * 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
EP2987788A1 (en) 2002-05-17 2016-02-24 Taiwanj Pharmaceuticals Co., Ltd. Opioid and opioid-like compounds and uses thereof
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
CN103073496B (en) * 2013-02-18 2015-08-26 苏州立新制药有限公司 The preparation method of Dextromethorphane Hbr
KR102102513B1 (en) 2014-10-14 2020-04-20 히사미쓰 세이야꾸 가부시키가이샤 Adhesive patch

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3166559A (en) * 1965-01-19 J-lower alkoxy-x-phenyloxy-ix-hydroxy-
GB1028407A (en) * 1962-04-06 1966-05-04 Shionogi & Co Improvements in or relating to morphinan derivatives and their preparation
FR1362540A (en) * 1963-04-05 1964-06-05 Shionogi & Co Substituted n derivatives of morphinan and their production

Also Published As

Publication number Publication date
DE2265255C2 (en) 1986-06-05
NL7212176A (en) 1973-03-12
IE36688B1 (en) 1977-02-02
SE403286B (en) 1978-08-07
FR2154481A1 (en) 1973-05-11
DE2265256C2 (en) 1985-10-24
HK2679A (en) 1979-01-19
CY980A (en) 1979-03-23
NL162072C (en) 1980-04-15
GB1412129A (en) 1975-10-29
DE2243961C2 (en) 1988-07-21
SE7506292L (en) 1975-06-02
AU470102B2 (en) 1976-03-04
SE398877B (en) 1978-01-23
CA999578A (en) 1976-11-09
NL162072B (en) 1979-11-15
DE2265255A1 (en) 1977-01-27
KE2911A (en) 1979-01-26
DE2243961A1 (en) 1973-04-05
US3819635A (en) 1974-06-25
DD100255A5 (en) 1973-09-12
YU45099B (en) 1992-07-20
DK141624B (en) 1980-05-12
IE36687B1 (en) 1977-02-02
DE2265256A1 (en) 1977-01-27
JPS5310596B2 (en) 1978-04-14
FR2154481B1 (en) 1976-04-23
MY7900027A (en) 1979-12-31
AU4622872A (en) 1974-03-07
CH590845A5 (en) 1977-08-31
GB1412130A (en) 1975-10-29
JPS4834864A (en) 1973-05-22
DK141624C (en) 1980-10-13
YU227772A (en) 1982-02-28
BE788478A (en) 1973-03-06

Similar Documents

Publication Publication Date Title
IE36687B1 (en) N-substituted-14-hydroxy-3-substituted morphinan derivatives
EP0823413A3 (en) Benzoheterocyclic compounds
GB1268243A (en) 0,2,4,5,-tetrahydro-3h,3-benzazepines
US2899437A (en) Pyridylethylated salicylamides
US4831134A (en) N-hydroxy hindered amine stabilizers
DE60141575D1 (en) PROCESS FOR THE PRODUCTION OF AMINETHERS FROM SECONDARY AMINOXIDES
US3390149A (en) Process for the production of beta-quinophthalines
GB1006337A (en) Improvements in or relating to 6-alkylmorphinan derivatives and their preparation
US2914551A (en) Fluorescent methine dyes
IE41382B1 (en) Benzylamine derivatives process for their production and pharmaceutical compositions containing them
US3534054A (en) 3,6-dioxo-2-aza-9,11,14-trioxadispiro (4.1.5.3) pentadecane
US4323684A (en) Process for preparing a 2,2,6,6-tetraalkyl-4-piperidyl spiro aliphatic ether
US4788315A (en) 2,5-substituted-cyclohexane-1,4-diones and a process for production thereof
US2323391A (en) Beta-amino acid amides and method of making same
US3775416A (en) S-triazolo(3,4-a)isoquinolines and derivatives thereof
US4339582A (en) Quinolizidine-propionanilide compounds
EP0503958B1 (en) Heterocyclic compounds and their production
US3437689A (en) Aromatic amino acid
US3062824A (en) Preparing vinylpyridine-n-oxides and certain derivatives thereof
GB1528799A (en) Dialkylphosphonopropionic acid amide derivatives process for their manufacture and their use
Berényi et al. Regioselective O-demethylation of aporphines with methanesulfonic acid/methionine: An efficient one-pot transformation of thebaine to (r)(-)-2-methoxyapomorphine
IE812161L (en) Cycloalkanes.
US4223148A (en) Polyalkyl-piperidine diols and process for their preparation
IE46003L (en) Morphinans
CH679043A5 (en)